Simethicone with or Without N-acetylcysteine As Premedication in Esophagogastroduodenoscopy: a Systematic Review and Meta-analysis

Overview

Journal Ann Gastroenterol

Date 2025 Jan 13

PMID 39802290

Authors

Caroline Tanadi

Fegita Beatrix Pajala

Yehuda Tri Nugroho Supranoto

Kevin Tandarto

Maureen Miracle Stella

Randy Adiwinata

Paulus Simadibrata

Marcellus Simadibrata

Affiliations

Soon will be listed here.

Abstract

Background: The impairment of gastrointestinal mucosa visibility during esophagogastroduodenoscopy (EGD), due to the presence of foam and bubbles, may lead to reduced quality in the EGD results. The combination of simethicone, a defoaming agent, along with N-acetylcysteine (NAC), which has mucolytic properties, has been proposed to improve the visibility of the mucosa. This study aimed to evaluate the effectiveness of pre-procedural administration of simethicone and N-acetylcysteine in improving mucosal visibility, procedure time and mucosal cleansing volume needed during EGD.

Methods: We conducted a comprehensive literature search from inception to November 23, 2023, in PubMed, CENTRAL, ProQuest, SAGE, and JSTOR. We included randomized clinical trials that investigated the effects of simethicone with or without NAC as premedication in EGD. For the quantitative analysis, standardized mean difference (SMD) was used to assess continuous outcomes and risk ratio for dichotomous outcomes. The Cochrane risk of bias 2 tool was used to evaluate the risk of bias.

Results: This meta-analysis comprised a total of 20 studies and found that simethicone with or without NAC improved mucosal visibility compared with control (SMD -1.27, 95% confidence interval [CI] -1.74 to -0.81, P<0.001). The combination of simethicone and NAC was significantly better than simethicone alone (SMD -0.68, 95%CI -1.08 to -0.28, P=0.001). Simethicone with or without NAC also shortened the procedure time compared to control (MD -1.40, 95%CI -2.67 to -0.12, P=0.03). The risk of bias was low with a moderate grade of certainty.

Conclusion: The administration of simethicone with or without NAC may improve EGD quality.

References

Chang W, Yeh M, Hsu H, Chen H, Hu M . Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy. J Gastroenterol Hepatol. 2013; 29(4):769-74. DOI: 10.1111/jgh.12487. View

Hultcrantz M, Rind D, Akl E, Treweek S, Mustafa R, Iorio A . The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017; 87:4-13. PMC: 6542664. DOI: 10.1016/j.jclinepi.2017.05.006. View

Misawa M, Imamura N . [In vitro evaluation of mucolytic activities of some expectorants using porcine gastric mucin]. Nihon Yakurigaku Zasshi. 1988; 92(4):263-70. DOI: 10.1254/fpj.92.263. View

Elvas L, Areia M, Brito D, Alves S, Saraiva S, Cadime A . Premedication with simethicone and N-acetylcysteine in improving visibility during upper endoscopy: a double-blind randomized trial. Endoscopy. 2016; 49(2):139-145. DOI: 10.1055/s-0042-119034. View

Monrroy H, Vargas J, Glasinovic E, Candia R, Azua E, Galvez C . Use of N-acetylcysteine plus simethicone to improve mucosal visibility during upper GI endoscopy: a double-blind, randomized controlled trial. Gastrointest Endosc. 2017; 87(4):986-993. DOI: 10.1016/j.gie.2017.10.005. View

Bertoni G, Gumina C, Conigliaro R, Ricci E, Staffetti J, Mortilla M . Randomized placebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy. Endoscopy. 1992; 24(4):268-70. DOI: 10.1055/s-2007-1010479. View

Basford P, Brown J, Gadeke L, Fogg C, Haysom-Newport B, Ogollah R . A randomized controlled trial of pre-procedure simethicone and N-acetylcysteine to improve mucosal visibility during gastroscopy - NICEVIS. Endosc Int Open. 2016; 4(11):E1197-E1202. PMC: 5110361. DOI: 10.1055/s-0042-117631. View

Chang C, Chen S, Lin C, Hsieh C, Lou H, Suk F . Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study. World J Gastroenterol. 2007; 13(3):444-7. PMC: 4065902. DOI: 10.3748/wjg.v13.i3.444. View

Veitch A, Uedo N, Yao K, East J . Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Rev Gastroenterol Hepatol. 2015; 12(11):660-7. DOI: 10.1038/nrgastro.2015.128. View

10.

Stepan M, Fojtik P, Psar R, Hanousek M, Sabol M, Zapletalova J . Administration of maximum dose of mucolytic solution before upper endoscopy - a double-blind, randomized trial. Eur J Gastroenterol Hepatol. 2023; 35(6):635-640. PMC: 10144268. DOI: 10.1097/MEG.0000000000002559. View

11.

Ahsan M, Babaei L, Gholamrezaei A, Emami M . Simethicone for the Preparation before Esophagogastroduodenoscopy. Diagn Ther Endosc. 2011; 2011:484532. PMC: 3150153. DOI: 10.1155/2011/484532. View

12.

Krishnamurthy V, Joseph A, Venkataraman S, Kurian G . Simethicone and N-acetyl cysteine combination as premedication before esophagogastroduodenoscopy: Double-blind randomized controlled trial. Endosc Int Open. 2022; 10(5):E585-E592. PMC: 9106414. DOI: 10.1055/a-1782-2003. View

13.

Stepan M, Falt P, Pipek B, Fojtik P, Hanousek M, Hill M . Administration of mucolytic solution before upper endoscopy - double-blind, monocentric, randomized study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021; 167(1):69-73. DOI: 10.5507/bp.2021.038. View

14.

Liu X, Guan C, Xue L, He S, Zhang Y, Zhao D . Effect of premedication on lesion detection rate and visualization of the mucosa during upper gastrointestinal endoscopy: a multicenter large sample randomized controlled double-blind study. Surg Endosc. 2018; 32(8):3548-3556. PMC: 6061056. DOI: 10.1007/s00464-018-6077-4. View

15.

Zuberi B, Shaikh M, Ali F, Rasheed T, Nawaz Z . Effect of pre-endoscopy intake of simethicone solution on endoscopic mucosal visibility: A single blinded, placebo control, randomized trial. Pak J Med Sci. 2020; 36(2):172-176. PMC: 6994877. DOI: 10.12669/pjms.36.2.1241. View

16.

Cao L, Zheng F, Wang D, Chen L, Feng X, Zhou Z . The Effect of Using Premedication of Simethicone/Pronase With or Without Postural Change on Visualization of the Mucosa Before Endoscopy: A Prospective, Double Blinded, Randomized Controlled Trial. Clin Transl Gastroenterol. 2023; 15(2):e00625. PMC: 10887445. DOI: 10.14309/ctg.0000000000000625. View

17.

Early D, Ben-Menachem T, Decker G, Evans J, Fanelli R, Fisher D . Appropriate use of GI endoscopy. Gastrointest Endosc. 2012; 75(6):1127-31. DOI: 10.1016/j.gie.2012.01.011. View

18.

Manfredi G, Berte R, Iiritano E, Alicante S, Londoni C, Brambilla G . Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population. Endosc Int Open. 2021; 9(2):E190-E194. PMC: 7834924. DOI: 10.1055/a-1315-0114. View

19.

Duez L, Gkolfakis P, Bastide M, Vuckovic C, Musala C, Van Gossum M . Premedication with simethicone for improving the quality of gastric mucosal visualization: a double-blind randomized controlled trial. Endosc Int Open. 2022; 10(10):E1343-E1349. PMC: 9576330. DOI: 10.1055/a-1922-7773. View

20.

Mahawongkajit P, Kanlerd A . A prospective randomized controlled trial comparing simethicone, N-acetylcysteine, sodium bicarbonate and peppermint for visualization in upper gastrointestinal endoscopy. Surg Endosc. 2020; 35(1):303-308. DOI: 10.1007/s00464-020-07397-8. View